Neurocrine Bio. (NBIX) PT Raised to $200 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Phil Nadeau raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $200.00 (from $175.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
